Value of toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis

Pediatric Infectious Disease Journal

Volumn 26, Issue 9, 2007, Pages 845-846

  Fricker Hidalgo, Hélène ^a   Brenier Pinchart, Marie Pierre ^a   Schaal, Jean Patrick ^a   Equy, Véronique ^a   Bost Bru, Cécile ^a   Pelloux, Hervé ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Congenital toxoplasmosis; Mouse inoculation; PCR; Placenta

Indexed keywords

FANSIDAR; SPIRAMYCIN;

ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEWBORN; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TOXOPLASMA GONDII;

ANIMALS; ANTI-INFECTIVE AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MICE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PYRIMETHAMINE; SENSITIVITY AND SPECIFICITY; SPIRAMYCIN; SULFADOXINE; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 34548208312     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318123e8d3     Document Type: Article

References (10)

1. McLeod R, Boyer K, Karrison T, et al.; for the Toxoplasmosis Study Group. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the national collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis. 2006;42:1383-1394.
2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-1976.
3. Bessières MH, Berribi A, Rolland M, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal test. Eur J Obstet Gynecol Reproduct Biol. 2001;94:37-45.
4. Fricker-Hidalgo H, Pelloux H, Racinet C, et al. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitrocultures. Placenta. 1998;19:545-549.
5. Pelloux H, Guy E, Angelici MC, et al. A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Lett. 1998;165:231-237.
6. Tissot-Dupont D, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2003;22:122-125.
7. Gratzl R, Sodeck G, Platzer P, Jäger W, Graf J. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur J Clin Microbiol Infect Dis. 2002;21:12-16.
8. Ajzenberg D, Cogné N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis. 2002;186:684-689.
9. Barragan A, Sibley LD. Migration of Toxoplasma gondii across biological barriers. Trends Parasitol. 2003;11:426-430.
10. Thalib L, Gras L, Romand S, et al. ; for the European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. Br J Obstet Gynaecol. 2005;112:567-574.